Early testing for Alzheimer’s | Science News

Real Science. Real News.

Science News is a nonprofit.

Support us by subscribing now.


Early testing for Alzheimer’s

Spinal fluid compounds can predict in many cases whether people with mild cognitive impairments will develop the disease

4:15pm, July 21, 2009

Elderly people with mild cognitive losses are at a heightened risk of progressing to Alzheimer’s disease if they have a combination of telltale compounds in their spinal fluid, researchers report in the July 22/29 Journal of the American Medical Association.

By testing for a shortage of a sticky compound called amyloid-beta in the spinal fluid and for excess amounts of two kinds of a protein called tau, the scientists could identify people at greatest risk.

The test isn’t foolproof, and a positive reading still warns of a disease for which there is no cure. But scientists are heartened by this and earlier studies (SN: 9/20/03, p. 179)because Alzheimer’s disease is difficult to foresee and its early symptoms are often mistaken for routine cognitive losses caused by aging.

Niklas Mattsson of a Gothenburg University-affiliated hospital in Mölndal, Sweden, and an international group of scientists recruited 750 elderly pe

This article is only available to Science News subscribers. Already a subscriber? Log in now.
Or subscribe today for full access.

Get Science News headlines by e-mail.

More from Science News

From the Nature Index Paid Content